Wells Fargo’s Intellipharmaceuticals International Inc. IPCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3
| Closed | – | – | 6703 |
|
|
2018
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 6779 |
|
|
2018
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 6726 |
|
|
2018
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 6752 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 6713 |
|
|
2017
Q4 | $0 | Sell |
3
-100
| -97% | -$908 | ﹤0.01% | 6668 |
|
|
2017
Q3 | $1K | Hold |
103
| – | – | ﹤0.01% | 6264 |
|
|
2017
Q2 | $2K | Sell |
103
-1
| -1% | -$21 | ﹤0.01% | 6070 |
|
|
2017
Q1 | $3K | Hold |
104
| – | – | ﹤0.01% | 6139 |
|
|
2016
Q4 | $3K | Hold |
104
| – | – | ﹤0.01% | 6066 |
|
|
2016
Q3 | $2K | Hold |
104
| – | – | ﹤0.01% | 6070 |
|
|
2016
Q2 | $2K | Hold |
104
| – | – | ﹤0.01% | 5969 |
|
|
2016
Q1 | $2K | Buy |
104
+1
| +1% | +$22 | ﹤0.01% | 6061 |
|
|
2015
Q4 | $2K | Hold |
103
| – | – | ﹤0.01% | 6046 |
|
|
2015
Q3 | $2K | Hold |
103
| – | – | ﹤0.01% | 6018 |
|
|
2015
Q2 | $3K | Buy |
103
+100
| +3,333% | +$3.02K | ﹤0.01% | 6129 |
|
|
2015
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 6479 |
|
|
2014
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 6530 |
|
|
2014
Q3 | $0 | Buy |
3
+1
| +50% | +$29 | ﹤0.01% | 6446 |
|
|
2014
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 6389 |
|
|
2014
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 6196 |
|
|
2013
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 6041 |
|
|
2013
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 5943 |
|
|
2013
Q2 | $0 | Buy |
+2
| New | +$37 | ﹤0.01% | 5770 |
|
Wells Fargo's IPCI Position: Q1 2019 in Review
Wells Fargo sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 3 shares.
Wells Fargo first reported a position in IPCI in Q2 2013 and held it in 23 quarters. The position peaked at $3K in Q1 2017. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.
- Wells Fargo reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
- Wells Fargo sold 3 Intellipharmaceuticals International Inc. shares in Q1 2019.
- Wells Fargo first reported a position in Intellipharmaceuticals International Inc. in Q2 2013 and held it in 23 quarters.
- Wells Fargo's Intellipharmaceuticals International Inc. position peaked at $3K in Q1 2017.
- 0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.
Based on Wells Fargo's 13F filing for Q1 2019, filed 10 May 2019.